Below are the top earnings and/or revenue beats for the week ending November 10, 2017. The table below is sorted by the biggest beats in descending order (at the top).
Strong technical setup with bullish sentiment from analysts. The company is also a strong seasonal play. The company was also recently ranked #11 on Fortune's 100 Fastest Growing Companies list.
Pivotal Research raised USANA Health Sciences price target to $80 from $70 which represents 16.4% upside from the current price of $68.70. Pivotal Research has a Buy rating on the
The FDA has granted priority review for Exelixis Cabomteyx. The sNDA seeks approval of Cabometyx for patients with previously untreated advanced renal cell carcinoma (RCC). The FDA determined the sNDA
USANA Health Sciences' Twiggs Money Flow is rocketing higher on the launch of two new products in Canada. USANA has launched Prenatal CellSentials® and MagneCal D™ products in Canada. The
Cryoport stock received a price target hike from Janney Montgomery Scott to $12 which is 42% upside from the previous close of $8.45. Cryoport provides cryogenic logistics solutions to the life
The stock chart of Cerner Corporation shows a momentum squeeze candidate on excellent sales growth and new business from the Carolinas HealthCare System (CHS). Cerner announced on June 21, 2017, that
May 18, 2017: S&P raises Centene's rating one notch to BB+ from BB with an outlook rating of stable. "The rating upgrade on Centene reflects the company's continued successful execution
April 16, 2017: Sell Catalyst Pharmaceuticals for a 47% gain in 60 days and congratulations if you made money on the trade. January 4, 2017: The popular SeekingAlpha blogger Hawkinvest, with